Current Clinical Trials
Department: Oncology
Diagnosis: Breast
Principal Investigator: Lynch MD, Cynthia A.
Sub-Investigator(s):
Sponsor: SCUSF
Indentifier #: NCT01009918
Title: SCUSF-0806, Phase II placebo-controlled trial of lisinopril and Coreg CR to reduce cardiotoxicity in patients with breast cancer receiving (neo)adjuvant chemotherapy with trastuzumab (Herceptin)
Department: Oncology
Diagnosis: Hematology- Leukemia
Principal Investigator: O'Brien M.D., Edward Thomas
Sub-Investigator(s):
Sponsor: Merck & Co.
Indentifier #: NCT01580228
Title: MK-7965 PN 012: A Phase III Study to Evaluate the Efficacy and Safety of Dinaciclib or Ofatumumab in Subjects with Refractory Chronic Lymphocytic Leukemia (CLL).
Department: Cardiology
Diagnosis: Cardiac - Device
Principal Investigator: Deshmukh MD FACC MRCP, Pramod
Sub-Investigator(s):
Sponsor: St. Jude Medical
Indentifier #: NCT01424722
Title: ST Monitoring to Detect ACS Events in ICD Patients (Analyze
ST)
Department: Gastroenterology
Diagnosis: Gastrointestinal - Irritable Bowel Syndrome
Principal Investigator: McDonald M.D., Thomas
Sub-Investigator(s):
Sponsor: Salix
Indentifier #: NCT01543178
Title: A Study to Assess Repeat Treatment Efficacy and Safety of Rifaximin 550 mg TID in Subjects With Irritable Bowel Syndrome With Diarrhea (IBS-D) (RFIB3053)
Department: Oncology
Diagnosis: Breast- Metastatic
Principal Investigator: Lynch MD, Cynthia A.
Sub-Investigator(s):
Sponsor: Genentech
Indentifier #: NCT01615068
Title: Genentech ML 28257; An Observational Cohort Study of Treatment Patterns and Outcomes in Patients with HER2 Positive (HER2+) Metastatic Breast Cancer